ATE407148T1 - Gruppe-2-allergen-spezifische igg-moleküle und deren verwendung - Google Patents

Gruppe-2-allergen-spezifische igg-moleküle und deren verwendung

Info

Publication number
ATE407148T1
ATE407148T1 AT01273005T AT01273005T ATE407148T1 AT E407148 T1 ATE407148 T1 AT E407148T1 AT 01273005 T AT01273005 T AT 01273005T AT 01273005 T AT01273005 T AT 01273005T AT E407148 T1 ATE407148 T1 AT E407148T1
Authority
AT
Austria
Prior art keywords
group
allergen
specific igg
igg molecules
fabs
Prior art date
Application number
AT01273005T
Other languages
English (en)
Inventor
Sabine Flicker
Peter Steinberger
Dietrich Kraft
Rudolf Valenta
Original Assignee
Phadia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phadia Ab filed Critical Phadia Ab
Application granted granted Critical
Publication of ATE407148T1 publication Critical patent/ATE407148T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/16—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from plants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G01N33/6857—Antibody fragments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55—Fab or Fab'

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Botany (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT01273005T 2000-12-29 2001-12-27 Gruppe-2-allergen-spezifische igg-moleküle und deren verwendung ATE407148T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0004892A SE0004892D0 (sv) 2000-12-29 2000-12-29 Group 2 allergen specific IgE-Fabs and use thereof

Publications (1)

Publication Number Publication Date
ATE407148T1 true ATE407148T1 (de) 2008-09-15

Family

ID=20282467

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01273005T ATE407148T1 (de) 2000-12-29 2001-12-27 Gruppe-2-allergen-spezifische igg-moleküle und deren verwendung

Country Status (10)

Country Link
EP (1) EP1351988B1 (de)
JP (1) JP2004532813A (de)
AT (1) ATE407148T1 (de)
CA (1) CA2429636C (de)
DE (1) DE60135677D1 (de)
DK (1) DK1351988T3 (de)
ES (1) ES2315259T3 (de)
SE (1) SE0004892D0 (de)
SI (1) SI1351988T1 (de)
WO (1) WO2002053595A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1718974A2 (de) * 2004-02-26 2006-11-08 Alk-Abell A/S Verfahren zur bewertung des therapeutischen potentials eines impfstoff zur mukosalen verabreichung
EP1922332A2 (de) * 2005-09-09 2008-05-21 The University Of Chicago Verfahren und zusammensetzungen zur diagnose und immuntherapie von pollenallergie
WO2015185767A1 (es) * 2014-06-04 2015-12-10 Abbcn, S.L. Etiquetas peptídicas para el marcaje de proteínas por fusión, y anticuerpos para su detección

Also Published As

Publication number Publication date
DE60135677D1 (de) 2008-10-16
CA2429636C (en) 2013-02-05
ES2315259T3 (es) 2009-04-01
EP1351988B1 (de) 2008-09-03
JP2004532813A (ja) 2004-10-28
DK1351988T3 (da) 2009-01-12
SE0004892D0 (sv) 2000-12-29
WO2002053595A1 (en) 2002-07-11
CA2429636A1 (en) 2002-07-11
EP1351988A1 (de) 2003-10-15
SI1351988T1 (sl) 2009-02-28

Similar Documents

Publication Publication Date Title
ATE532860T1 (de) B7-ähnliche moleküle und deren anwendungen
ATE194291T1 (de) Neutralisierende monoklonale antikörper gegen respiratorischen synzytialvirus
AT500379B1 (de) Tau-proteine
AR038568A1 (es) Anticuerpos anti-a beta y su uso
DE60137223D1 (de) Thymus-stroma lymphopoietin rezeptor-moleküle und deren verwendung
FR12C0004I2 (fr) Anticorps contre l'antigene ctla-4 humain et utilisation
ES2133813T3 (es) Cadenas de lamininas: diagnostico y uso terapeutico.
MXPA02011656A (es) Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos.
WO2001092308A3 (en) Cystine-knot polypeptides: cloaked-2 molecules and uses thereof
EP1409544A4 (de) Humane dr4-antikörper und deren anwendungen
TR200002731T2 (tr) Proteolitik antikorların indüktör ve inhibitörlerinin tanımlanması, kompozisyonları ve kullanımları için metotlar
DE60138715D1 (de) Tnf-rezeptor-ähnliche moleküle und deren anwendungen
WO2003104425A3 (en) NEW STABLE ANTI-CD22 ANTIBODIES
ATE385517T1 (de) Interferon ähnliche moleküle, und deren verwendungen
ATE407148T1 (de) Gruppe-2-allergen-spezifische igg-moleküle und deren verwendung
CA2393135A1 (en) Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
ATE290081T1 (de) Parietaria judaica ns-ltp-antigenvarianten, entsprechende pharmazeutische zusammensetzungen und ihre verwendung
DE69840628D1 (de) Nicht-anaphylaktische allergenarten und ihre verwendung
DE50010525D1 (de) Verfahren zur isolierung und aufreinigung von gräserpollenallergenen
WO2005023979A3 (en) Isolated s. mansoni nucleic acid molecules and uses thereof
DE60020970D1 (de) Monoklonaler antikörper mit selektiver bindung an vgf und verwendung zur behandlung von vgf-erkrankungen
DK1639110T3 (da) Rajgræspollenspecifikke promotorer og ekspressionskonstructer
ATE302213T1 (de) Nicht-anaphylaktische formen des grasspollenallergens ph1 p 6 und deren verwendung
DE50210281D1 (de) Identifizierung von ses-1 aus c. elegans sowie dessen verwendung
WO2002044379A3 (en) Transforming growth factor-beta-related molecules and uses thereof

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties